ICU Medical Net Income Over Time
| ICUI Stock | USD 148.27 3.37 2.33% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ICU Medical Performance and ICU Medical Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will ICU introduce new products? Factors like these will boost the valuation of ICU Medical. Market participants price ICU higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (0.32) | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets |
ICU Medical's market price often diverges from its book value, the accounting figure shown on ICU's balance sheet. Smart investors calculate ICU Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since ICU Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Analysis
Compare ICU Medical and related stocks such as Arcutis Biotherapeutics, Dentsply Sirona, and Prestige Brand Holdings Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARQT | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (19.3 M) | (42 M) | (135.7 M) | (205.9 M) | (311.5 M) | (262.1 M) | (140 M) | (126 M) | (132.3 M) |
| XRAY | 100 K | 244.5 M | 314.2 M | 313.2 M | 322.9 M | 251.2 M | 429.9 M | (1.6 B) | (1 B) | 256 M | (73 M) | 411 M | (950 M) | (132 M) | (910 M) | (819 M) | (778 M) |
| PBH | 2.5 M | 37.2 M | 65.5 M | 72.6 M | 78.3 M | 99.9 M | 69.4 M | 339.6 M | (35.8 M) | 142.3 M | 164.7 M | 205.4 M | (82.3 M) | 209.3 M | 214.6 M | 246.8 M | 259.1 M |
| HAE | 13.8 M | 66.9 M | 38.8 M | 35.1 M | 16.9 M | (55.6 M) | (26.3 M) | 45.6 M | 55 M | 76.5 M | 79.5 M | 43.4 M | 115.4 M | 117.6 M | 167.7 M | 192.8 M | 202.5 M |
| LIVN | (5.1 M) | 36.1 M | 46.4 M | 54.9 M | 54.9 M | 57.8 M | (62.8 M) | (25.1 M) | (189.4 M) | (157.6 M) | (348.8 M) | (135.8 M) | (86.2 M) | 17.5 M | 63.2 M | 56.9 M | 59.8 M |
| TVTX | (18.3 K) | (14.8 K) | (30.3 M) | (33.8 M) | (110.9 M) | 117.2 M | (47.9 M) | (59.7 M) | (102.7 M) | (146.4 M) | (169.4 M) | (180.1 M) | (278.5 M) | (111.4 M) | (321.5 M) | (289.4 M) | (274.9 M) |
| HTFL | (95.7 M) | (95.7 M) | (95.7 M) | (95.7 M) | (95.7 M) | (95.7 M) | (95.7 M) | (95.7 M) | (95.7 M) | (95.7 M) | (95.7 M) | (95.7 M) | (95.7 M) | (95.7 M) | (96.4 M) | (86.8 M) | (91.1 M) |
| PRGO | 28.6 M | 401.6 M | 441.9 M | 205.3 M | 205.3 M | 127.9 M | (4 B) | 119.6 M | 131 M | 146.1 M | (162.6 M) | (68.9 M) | (140.6 M) | (12.7 M) | (171.8 M) | (154.6 M) | (146.9 M) |
| TARS | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (4.7 M) | (26.8 M) | (13.8 M) | (62.1 M) | (135.9 M) | (115.6 M) | (104 M) | (98.8 M) |
| IRON | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (40.8 M) | (36 M) | (46.1 M) | (76.4 M) | (109.4 M) | (98.4 M) | (103.3 M) |
ICU Medical and related stocks such as Arcutis Biotherapeutics, Dentsply Sirona, and Prestige Brand Holdings Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in ICU Medical financial statement analysis. It represents the amount of money remaining after all of ICU Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| ICU Medical | ICUI |
| Classification | Obamacare Repeal |
| Business Address | 951 Calle Amanecer, |
| Exchange | NASDAQ Exchange |
USD 148.27
Check out ICU Medical Performance and ICU Medical Correlation. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
ICU Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.